Resolution of mycobacterium abscessus disease following initiation of elexacaftor/tezacaftor/ ivacaftor

被引：0
|
作者：
Gavey, R. [1 ]
Moore, V [2 ]
Nolan, J. [2 ]
Reid, D. [2 ]
Brown, J. [1 ]
机构：
[1] Cairns Hosp & Hlth Serv, Dept Thorac & Sleep Med, Cairns, Australia
[2] Prince Charles Hosp, Dept Thorac Med, Adult Cyst Fibrosis Ctr, Chermside, Australia
来源：
RESPIROLOGY | 2024年 / 29卷
关键词：
Cystic fibrosis; Nontuberculous mycobacterium; Mycobacterium abscessus; Elexacaftor/Tezacaftor/; Ivacaftor;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TP074
引用
收藏
页码：162 / 162
页数：1
相关论文
共 50 条
  • [41] ELEXACAFTOR-TEZACAFTOR-IVACAFTOR IN ADULT HISPANIC PATIENTS
    Ortiz, Tupayachi M. G.
    Richter, J.
    Morris, S.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S298 - S298
  • [42] Cystic Fibrosis: Triple Therapy with Elexacaftor, Tezacaftor and Ivacaftor
    Lorenz, Judith
    PNEUMOLOGIE, 2022, 76 (03): : 153 - 153
  • [43] Elexacaftor-Tezacaftor-Ivacaftor Therapy for Chronic Sinus Disease in Cystic Fibrosis
    Sheikh, Shahid
    Ho, Mai-Lan
    Eisner, Mariah
    Gushue, Courtney
    Paul, Grace
    Holtzlander, Melissa
    Johnson, Terri
    McCoy, Karen S.
    Lind, Meredith
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2023, 149 (12) : 1075 - 1082
  • [44] The efficacy of Elexacaftor/Tezacaftor/Ivacaftor in patients with cystic fibrosis and advanced lung disease
    O'Carroll, O. M.
    O'Shea, K. M.
    Carroll, C.
    Grogan, B.
    Connolly, A.
    O'Shaughnessy, L.
    Nicholson, T.
    Gallagher, C. G.
    McKone, E. F.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 1) : S16 - S16
  • [45] Is Elexacaftor/Tezacaftor/Ivacaftor Effective in Treating Sinonasal Disease in Patients with Cystic Fibrosis?
    Merrill, Tyler B.
    Tyes, Jonathan
    Woodard, Troy D.
    LARYNGOSCOPE, 2024, 134 (02): : 501 - 503
  • [46] Optimism with Caution: Elexacaftor-Tezacaftor-Ivacaftor in Patients with Advanced Pulmonary Disease
    Kuek, Stephanie L.
    Ranganathan, Sarath C.
    Harrison, Joanne
    Robinson, Philip J.
    Shanthikumar, Shivanthan
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 204 (03) : 371 - 372
  • [47] Tolerance of elexacaftor/tezacaftor/ivacaftor in Australians with cystic fibrosis
    Ruseckaite, Rasa
    Wark, Peter
    Pourghaderi, Ahmadreza
    Caruso, Marisa
    Ahern, Susannah
    RESPIROLOGY, 2024, 29 : 8 - 8
  • [48] Plasma Proteome Identifies Inflammatory Signal Differences Before and After Elexacaftor/Tezacaftor/Ivacaftor Initiation
    Skala, E.
    Siefert, M. E.
    Dusa, C.
    Stevens, C.
    Hils, B.
    Hayes, D.
    Ziady, A. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [49] DISEASE MODULATION BY ELEXACAFTOR/TEZACAFTOR/IVACAFTOR IN CYSTIC FIBROSIS PATIENTS WITH SEVERE LUNG DISEASE
    Wright, E.
    Megram, E.
    Vardon, P.
    Cobb, R.
    Burgess, K.
    Moore, V
    Loel, F.
    Smith, D.
    Tay, G.
    France, M.
    Reid, D.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S221 - S222
  • [50] Ivacaftor-tezacaftor-elexacaftor (Trikafta) in pregnancy and lactation
    Schneider-Futschik, E.
    Habgood, M.
    RESPIROLOGY, 2022, 27 : 141 - 141
12345